← 返回

通过对肿瘤空间蛋白质组学图谱的反事实学习,识别能够促进 T 细胞浸润肿瘤的扰动因素

英文原题:Identifying perturbations that boost T-cell infiltration into tumours via counterfactual learning of their spatial proteomic profiles.

查看英文原题

Identifying perturbations that boost T-cell infiltration into tumours via counterfactual learning of their spatial proteomic profiles.

PubMed 2025/03/05(内容时间) Nat Biomed Eng Q1 · IF 26.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

癌症进展可以通过激活内源性或工程化T细胞及其对肿瘤微环境的浸润来减缓或阻止。在此,我们描述了一种深度学习模型,该模型利用肿瘤的大规模空间蛋白质组学图谱来生成增强T细胞浸润的最小肿瘤扰动。该模型将用于生成扰动的反事实优化策略与作为自监督机器学习问题的T细胞浸润预测相结合。我们将该模型应用于使用40-plex成像质谱流式细胞术检测的368个转移性黑色素瘤和结直肠癌样本,并发现了队列依赖性的组合扰动(黑色素瘤为CXCL9、CXCL10、CCL22和CCL18,结直肠癌为CXCR4、PD-1、PD-L1和CYR61),这些扰动支持跨患者队列的T细胞浸润,并已通过体外实验证实。利用基于反事实的空间组学数据预测可能有助于癌症治疗药物的设计。

展开英文摘要原文

Cancer progression can be slowed down or halted via the activation of either endogenous or engineered T cells and their infiltration of the tumour microenvironment.

Here we describe a deep-learning model that uses large-scale spatial proteomic profiles of tumours to generate minimal tumour perturbations that boost T-cell infiltration. The model integrates a counterfactual optimization strategy for the generation of the perturbations with the prediction of T-cell infiltration as a self-supervised machine learning problem.

We applied the model to 368 samples of metastatic melanoma and colorectal cancer assayed using 40-plex imaging mass cytometry, and discovered cohort-dependent combinatorial perturbations (CXCL9, CXCL10, CCL22 and CCL18 for melanoma, and CXCR4, PD-1, PD-L1 and CYR61 for colorectal cancer) that support T-cell infiltration across patient cohorts, as confirmed via in vitro experiments. Leveraging counterfactual-based predictions of spatial omics data may aid the design of cancer therapeutics.

论文信息

作者
Wang ZJ、Farooq AS、Chen YJ、Bhargava A、Xu AM、Thomson MW
第一作者单位
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. jerry@westlake.edu.cn.United States
通讯作者单位
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. mthomson@caltech.edu.United States
期刊
Nature biomedical engineering2025 Mar
原文标识
PubMed 40044819 · DOI 10.1038/s41551-025-01357-0